Le Lézard
Classified in: Health, Science and technology, Business
Subject: SHAREHOLDER RIGHTS PLANS

Kane Biotech Announces Granting of Options


WINNIPEG, Manitoba, April 17, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the "Corporation" or "Kane Biotech"), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announces that it has granted an aggregate of 1,775,000 stock options at an exercise price of $0.10 per common share to directors, management, employees and consultants of the Corporation. The grant date of these stock options is October 23, 2018.

The options pursuant to the Corporation's stock option plan are subject to TSX Venture Exchange acceptance. In accordance with securities regulatory requirements, any shares issued pursuant to the exercise of such options will be subject to resale restriction for a period of four months from the date of the grant.

About Kane Biotech
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Corporation has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by the Corporation's own biofilm research expertise and acquired from leading research institutions. StrixNB(TM), DispersinB(R), Aledex(R), bluestem(TM), AloSera(TM), coactiv+(TM) and Kane(R) are trademarks of Kane Biotech Inc. The Corporation is listed on the TSX Venture Exchange under the symbol "KNE".

For more information, please visit www.kanebiotech.com or contact: 
Marc Edwards 
Chief Executive Officer 
Kane Biotech Inc. 
+1 (514) 910-6991[email protected] 
  
Grant Humphrey 
Vice President, Sales and Business Development 
Kane Biotech Inc. 
+1 (204) 914-5089[email protected]
  
Joe Green 
US. Investor Relations 
Edison Inc. 
+1 (646) 653-7030[email protected] 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Information
This press release contains certain statements regarding Kane Biotech Inc. that constitute forward-looking information under applicable securities law. These statements reflect management's current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, risks relating to the Company's: (a) financial condition, including lack of significant revenues to date and reliance on equity and other financing; (b) business, including its early stage of development, government regulation, market acceptance for its products, rapid technological change and dependence on key personnel; (c) intellectual property including the ability of the Company to protect its intellectual property and dependence on its strategic partners; and (d) capital structure, including its lack of dividends on its common shares, volatility of the market price of its common shares and public company costs. Further information about these and other risks and uncertainties can be found in the disclosure documents filed by the Company with applicable securities regulatory authorities, available at www.sedar.com. The Company cautions that the foregoing list of factors that may affect future results is not exhaustive.

 


These press releases may also interest you

at 19:00
Quhuo Limited ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on life services in China, today announced that it will report unaudited financial results for the second half and full year 2023 before the open of the...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:53
The American Council of Engineering Companies (ACEC) of California announced today the recipients of its 2024-25 Scholarship Foundation scholarships. ACEC California's Scholarship Foundation awards annual scholarships to accomplished graduate or...

at 18:50
Doma Holdings, Inc. , a leading force for innovation in the real estate industry, today announced that it has entered into a definitive agreement and plan of merger (the "transaction") with Title Resources Group ("TRG"), one of the nation's leading...

at 18:35
McorpCX, a leading customer and employee experience consultancy, and CX capabilities builder driving greater customer centricity since its founding in 2002, today announced the acquisition of UK-based myCXvision, a customer experience management...

at 18:30
The "Digital Banking - Global Strategic Business Report" has been added to  ResearchAndMarkets.com's offering. The global market for Digital Banking estimated at US$21.1 Billion in the year 2023, is projected to reach a revised size of US$53.5...



News published on and distributed by: